Cerebral venous thrombosis
- 8 April 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 60 (7) , 1175-1178
- https://doi.org/10.1212/01.wnl.0000055811.05743.10
Abstract
The authors studied 16 consecutive cases of cerebral venous thrombosis (CVT). Clinical outcome was good or excellent in 14 patients. Comprehensive hypercoagulable screening was done at least 3 months after the onset of CVT, including evaluation of genetic coagulation disorders and plasma levels of homocysteine and factor VIII. This screening was positive in 12 patients (75%). An acquired prothrombotic factor was identified in 9 of these 12 patients. Elevation of factor VIII plasma level was the most common coagulation disorder (8 patients).Keywords
This publication has 10 references indexed in Scilit:
- A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibilityBlood, 2003
- Elevated Factor VIII Levels and the Risk of ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- High Plasma Levels of Factor VIII and the Risk of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2000
- Changing Pattern of Headache Pointing to Cerebral Venous Thrombosis After Lumbar Puncture and Intravenous High‐Dose CorticosteroidsHeadache: The Journal of Head and Face Pain, 1999
- Randomized, Placebo-Controlled Trial of Anticoagulant Treatment With Low-Molecular-Weight Heparin for Cerebral Sinus ThrombosisStroke, 1999
- High Risk of Cerebral-Vein Thrombosis in Carriers of a Prothrombin-Gene Mutation and in Users of Oral ContraceptivesNew England Journal of Medicine, 1998
- Hyperhomocysteinemia and Venous Thrombosis: A Meta-analysisThrombosis and Haemostasis, 1998
- A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosisBlood, 1996
- Coagulation Studies, Factor V Leiden, and Anticardiolipin Antibodies in 40 Cases of Cerebral Venous ThrombosisStroke, 1996
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994